A detailed history of Rothschild Investment LLC transactions in Repligen Corp stock. As of the latest transaction made, Rothschild Investment LLC holds 451 shares of RGEN stock, worth $64,889. This represents 0.0% of its overall portfolio holdings.

Number of Shares
451
Previous 450 0.22%
Holding current value
$64,889
Previous $56.7 Million 18.32%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$119.79 - $167.35 $119 - $167
1 Added 0.22%
451 $67.1 Million
Q2 2024

Jul 30, 2024

BUY
$120.0 - $182.95 $54,000 - $82,327
450 New
450 $56.7 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.98B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.